Influence of Methylprednisolone Pulse Therapy on Liver Function in Patients with Graves’ Orbitopathy
Purpose. Intravenous methylprednisolone (IVMP) pulse therapy is the first-line treatment in active moderate-to-severe Graves’ orbitopathy (GO) and dysthyroid optic neuropathy (DON). One of the adverse effects of this therapy is liver dysfunction that can be mild (ALT < 100 U/L), moderate (ALT: 10...
Saved in:
Main Authors: | Piotr Miśkiewicz, Anna Jankowska, Kinga Brodzińska, Justyna Milczarek-Banach, Urszula Ambroziak |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2018/1978590 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves’ Orbitopathy
by: Hiroyuki Eguchi, et al.
Published: (2015-01-01) -
IgG4 as a Biomarker in Graves’ Orbitopathy
by: Michał Olejarz, et al.
Published: (2021-01-01) -
Therapeutic Effect of Gypenosides on Antioxidant Stress Injury in Orbital Fibroblasts of Graves’ Orbitopathy
by: Chao Ma, et al.
Published: (2022-01-01) -
Evaluation of IL-29 in Euthyroid Patients with Graves’ Orbitopathy: A Preliminary Study
by: Bogusz Falkowski, et al.
Published: (2020-01-01) -
Changes of plasma cytokines content in Graves’ orbitopathy patients, could be potential markers
by: Ying Fu, et al.
Published: (2024-04-01)